Heart Failure and Cardiomyopathies

Shared Genetic Architecture Between Mental Disorders and Heart Failure Subtypes: A Comprehensive Multitrait Genome‐Wide Analysis Combined Prognostic Value of Cardiac Magnetic Resonance–Derived Myocardial Extracellular Volume and the Fibrosis‐4 Index in Patients With Heart Failure With Preserved Ejection Fraction Greater Neighborhood Resources Predict Reduced In‐Hospital Death for Children With Heart Failure and Cardiomyopathy Anthracycline Cardiotoxicity as Multicellular Network Failure: Cardiac Niche Reprogramming and Pathological Cell–Cell Communication Efficacy and Safety of Pharmacologic Therapies in Nonobstructive Hypertrophic Cardiomyopathy: A Systematic Review Plasminogen Activator Inhibitor‐1 Deficiency Exacerbates Pressure Overload‐Induced Cardiac Hypertrophy in Mice Evaluation of Acute Electrical and Hemodynamic Improvement During Left Bundle‐Branch Area Pacing Modalities for Resynchronization Therapy Nuclear Factor Kappa‐B Inducing Kinase‐ and Inhibitor of Nuclear Factor Kappa‐B Kinase Subunit Beta‐Binding Protein Promotes Pathological Cardiac Hypertrophy by Regulating Inhibitor of Nuclear Factor Kappa‐B Kinase Subunit Beta‐Mediated Nuclear Factor Kappa‐B Activation Putting the Brakes on Nuclear Rupture–Driven Remodeling in LMNA Cardiomyopathy Saving the Capillaries: FGFR1/KLB and MFG-E8 in Diabetic Hearts